BlueCloud follows the Uber model to streamline connections

By Maggie Lynch

- Last updated on GMT

(Image: Getty/ bogdan kosanovic)
(Image: Getty/ bogdan kosanovic)

Related tags Research Site selection Clinical trial CRO Health care CRO market research network

BlueCloud by HealthCarePoint releases DDIT mechanisms to create an Uber-like service for the health care industry – connecting providers and consumers, such a sponsors and CROs.

BlueCloud, an independent network system​ for health care and clinical research created by HealthCarePoint, this week announced the addition of its delivery, distribution, implementation, and tracking (DDIT) mechanisms.

President of BlueCloud Al Pacino told us that the addition of the DDIT applications to its global system allows the collaborative network to operate like Uber: Connecting providers like investigative trial sites, to industry consumers such as sponsors and contract research organizations (CROs).

The network also added the DDIT mechanisms in an aim to “modernize the health care and clinical research ecosystem using basic business and compliance principles and modern technology models, by simply connecting industry consumers,” ​Pacino said. Each mechanism or application is designed to streamline a component of clinical research

The delivery and distribution mechanisms within the BlueCloud system enable consumers to find the products, services, and technologies needed for clinical research through authorized channels. It also provides patient maps to help locate potential clinical trial participants, among other applications and tools to help connect providers and consumers.

“Whenever the sponsors need to identify investigative sites for their clinical trial they should not have to pay for the list of investigative sites or the directories of thousands of professionals at the sites in order to do site screening and have site accessibility, it’s free to the sponsor as a consumer.

"Sponsors then use the BlueCloud DDIT on-demand mechanisms to properly identify the investigative sites that they’re going to choose for their clinical. Once they chose their sites, just like Uber once we chose our driver, sponsors are able to connect to their chosen sites immediately using their own BlueCloud system and perform site competencies, feasibility and other screening activities at no cost to the sponsor,” ​Pacino explained.

Additionally, a centralized global tracking system keeps tabs on regulatory compliance.

Pacino said, “The BlueCloud System looks to modernize all aspects of healthcare and clinical research not just creating a temporary solution for a single problem. By modernizing the complete ecosystem the industry can ultimately be sustainable - when opportunities are provided to every stakeholder – everyone win.”

Related news

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more